Question remains over efficacy of Oxford Covid-19 vaccine

Paul Hunter Full interim analysis of the safety and efficacy of the Oxford COVID-19 vaccine – developed in partnership with AstraZeneca – has been published in the Lancet. This paper represents the most comprehensive set of results from any of the phase 3 trials of COVID-19 vaccines to date. These are still only interim results, meaning […]

The post Question remains over efficacy of Oxford Covid-19 vaccine appeared first on Blitz.

[Read More]

—–
Source: Weekly Blitz :: Writings


« Previous Post
Next Post »
 

Comments are closed. Please check back later.

 
 
 
1